Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn’s and Colitis (PREdiCCt) prospective cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring the Links Between Demographic, Clinical, and Dietary Influences on Inflammatory Bowel Disease Flares: Insights from the PREdiCCt Prospective Cohort Study

  • By

  • Nathan Constantine-Cooke

  • Beatriz Gros

  • Nikolas Plevris

  • Linda J Williams

  • Gareth-Rhys Jones

  • Janet Kyle

  • Nicholas A Kennedy

  • Victor Velasco-Pardo

  • Alexander Rudge

  • Debbie Alexander

  • Carl A Anderson

  • Maiara Brusco de Freitas

  • Lisa M Derr

  • Lauranne AAP Derikx

  • Sian Gilchrist

  • Paul Henderson

  • Graham W Horgan

  • Peter Irving

  • Christopher A Lamb

  • Luke Jostins-Dean

  • James O Lindsay

  • Jonathan MacDonald

  • Craig Mowat

  • Charles Murray

  • Miles Parkes

  • Spyros I Siakavellas

  • Catalina A Vallejos

  • Daniel R Gaya

  • Jonathan M Rhodes

  • Alexandra M Johnstone

  • Christopher J Weir

  • Charlie W Lees

  • August 1, 2026

Share

Original Source(s)

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn’s and Colitis (PREdiCCt) prospective cohort study

  • by Nathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, Linda J Williams, Gareth-Rhys Jones, Janet Kyle, Nicholas A Kennedy, Victor Velasco-Pardo, Alexander Rudge, Debbie Alexander, Carl A Anderson, Maiara Brusco de Freitas, Lisa M Derr, Lauranne AAP Derikx, Sian Gilchrist, Paul Henderson, Graham W Horgan, Peter Irving, Christopher A Lamb, Luke Jostins-Dean, James O Lindsay, Jonathan MacDonald, Craig Mowat, Charles Murray, Miles Parkes, Spyros I Siakavellas, Catalina A Vallejos, Daniel R Gaya, Jonathan M Rhodes, Alexandra M Johnstone, Christopher J Weir, Charlie W Lees

  • August 1, 2026

Related Content

Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis

Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases